Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor

Japanese Journal of Cancer Research

Volumn 91, Issue 12, 2000, Pages 1241-1249

  Fukasawa, Tomoki ^a,b   Chong, Ja Mun ^a,d   Sakurai, Shinji ^a   Koshiishi, Naoki ^a,b   Ikeno, Rie ^a   Tanaka, Akira ^a   Matsumoto, Yoshiro ^b   Hayashi, Yukiko ^c   Koike, Morio ^c   Fukayama, Masashi ^a,d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Allelic loss; C kit; Gastrointestinal stromal tumor; Genetic instability; NF2

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CHROMOSOME 14Q; CHROMOSOME 22Q; CHROMOSOME ARM; CHROMOSOME LOSS; CLINICAL ARTICLE; CONNECTIVE TISSUE TUMOR; CONTROLLED STUDY; EXON; FEMALE; FREQUENCY ANALYSIS; GASTROINTESTINAL TUMOR; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE MUTATION; GENETIC STABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; MUTATION RATE; NEUROFIBROMATOSIS; NONSENSE MUTATION; ONCOGENE C KIT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; RISK ASSESSMENT; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 22; EXONS; FEMALE; GASTROINTESTINAL NEOPLASMS; GENES, NEUROFIBROMATOSIS 2; GENETIC MARKERS; HUMANS; INTESTINAL NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MEMBRANE PROTEINS; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION, MISSENSE; NEUROFIBROMIN 2; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS C-KIT; STOMACH NEOPLASMS;

EID: 0034525682     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00910.x     Document Type: Article

References (33)

1. Differentiation and risk assessment of gastrointestinal stromal tumors
2. v mice
3. Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine
4. Requirement of c-kit for development of intestinal pacemaker system
5. Distributed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws/Ws mutant rats
6. W/kit gene required for interstitial cell of Cajal and for intestinal pacemaker activity
7. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
8. Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
9. Gastrointestinal stromal tumors-Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas
10. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal
11. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors
12. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas
13. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors
14. C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cell of Cajal)
15. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors
16. Exon scanning for mutation of the NF2 gene in schwannomas
17. Frequency and distribution of NF2 mutations in schwannomas
18. Telomerase activity in gastrointestinal stromal tumor (GIST)
19. Microsatellite instability in the progression of gastric carcinoma
20. Microsatellite instability and loss of heterozygosity in gastric lymphoma
21. Allelotype of adenoma and differentiated adenocarcinoma of the stomach
22. Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer
23. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors
24. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: A genetic model of meningioma progression
25. Comparative genomic hybridization study on pooled DNAs from tumors of one clinical-pathological entity
26. Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and shwannomas
27. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
28. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
29. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas
30. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer
31. Neurofibromatosis 2 gene in human colorectal cancer
32. Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers
33. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum. A pathologic analysis of 100 cases